Conference Highlights of the 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses, 26–30 June 2013, Montreal, Canada

Retrovirology

Toshiki Watanabe^1,10  William M Switzer¹  Lee Ratner²  Edward L Murphy^1,11  Masao Matsuoka³  Fabiola Martin⁸  Kathryn Jones⁹  Edgar Carvalho⁵  Ali Bazarbachi⁶  John Hiscott⁴  Benoit Barbeau⁷ 

[1] Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA;Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA;Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto, Japan;Lady Davis Insitute, Montreal, Canada;Immunology Department, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil;Department of Internal Medicine, American University of Beirut, Beirut, Lebanon;Département des sciences biologiques and BioMed Research Center, Université du Québec à Montréal, Room SB-3335, 2080 St-Urbain, Montréal, Québec, Canada;Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, UK;Basic Research Program, Cancer and Inflammation Program, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA;Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan;University of California San Francisco and Blood Systems Research Institute, San Francisco, CA, USA

关键词: HTLV-1-associated myelopathy/tropical spastic paraparesis;    Adult T-cell leukemia/lymphoma;    Foamy virus;    BLV;    HTLV-2;    HTLV-1;   

Others  :  802593
DOI  :  10.1186/1742-4690-11-19

 received in 2014-01-29, accepted in 2014-02-10,  发布年份 2014

【 摘 要 】

The 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses was held in Montreal, Québec from June 26^th to June 30^th, 2013 and was therefore hosted by a Canadian city for the first time. The major topic of the meeting was human T-lymphotropic viruses (HTLVs) and was covered through distinct oral and poster presentation sessions: clinical research, animal models, immunology, molecular and cellular biology, human endogenous and emerging exogenous retroviruses and virology. In this review, highlights of the meeting are provided by different experts for each of these research areas.

【 授权许可】

   
2014 Barbeau et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]de The G, Bomford R: An HTLV-I vaccine: why, how, for whom? AIDS Res Human Retroviruses 1993, 9:381-386.
• [2]Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E: Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007, 7:266-281.
• [3]Roucoux DF, Murphy EL: The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 2004, 6:144-154.
• [4]Mahieux R, Gessain A: HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects. Viruses 2011, 3:1074-1090.
• [5]Aida Y, Murakami H, Takahashi M, Takeshima SN: Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus. Front Microbiol 2013, 4:328.
• [6]Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, O’Mahony D, Janik JE, Bittencourt AL, Taylor GP, Yamaguchi K, Utsunomiya A, Tobinai K, Watanabe T: Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009, 27:453-459.
• [7]Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K, Nakamura S, Inagaki H, Ohshima K, Kiyoi H, Ishida T, Matsushima K, Akinaga S, Ogura M, Tomonaga M, Ueda R: Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 2010, 28:1591-1598.
• [8]Yamano Y, Sato T, Araya N, Yagishita N, Shimizu Y, Ando H, Utsunomiya A, Izumo S, Jacobson S, Suzuki N: Clinical subtype of HAM/TSP based on clinical course and laboratory findings [abstract]. Retrovirology 2011, 8:A42. BioMed Central Full Text
• [9]Bazarbachi A, Nasr R, El-Sabban ME, Mahe A, Mahieux R, Gessain A, Darwiche N, Dbaibo G, Kersual J, Zermati Y, Dianoux L, Chelbi-Alix MK, de The H, Hermine O: Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma. Leukemia 2000, 14:716-721.
• [10]Bazarbachi A, Plumelle Y, Carlos Ramos J, Tortevoye P, Otrock Z, Taylor G, Gessain A, Harrington W, Panelatti G, Hermine O: Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol 2010, 28:4177-4183.
• [11]Marcais A, Suarez F, Sibon D, Frenzel L, Hermine O, Bazarbachi A: Therapeutic options for adult T-cell leukemia/lymphoma. Curr Oncol Rep 2013, 15:457-464.
• [12]Afonso PV, Mekaouche M, Mortreux F, Toulza F, Moriceau A, Wattel E, Gessain A, Bangham CR, Dubreuil G, Plumelle Y, Hermine O, Estaquier J, Mahieux R: Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood 2010, 116:3802-3808.
• [13]Kchour G, Rezaee R, Farid R, Ghantous A, Rafatpanah H, Tarhini M, Kooshyar MM, El Hajj H, Berry F, Mortada M, Nasser R, Shirdel A, Dassouki Z, Ezzedine M, Rahimi H, Ghavamzadeh A, de The H, Hermine O, Mahmoudi M, Bazarbachi A: The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma. Retrovirology 2013, 10:91. BioMed Central Full Text
• [14]Lezin A, Gillet N, Olindo S, Signate A, Grandvaux N, Verlaeten O, Belrose G, de Carvalho BM, Hiscott J, Asquith B, Burny A, Smadja D, Cesaire R, Willems L: Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients. Blood 2007, 110:3722-3728.
• [15]Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM) [http://clinicaltrials.gov/ct2/show/NCT00681980?term=ham+tsp&rank=6 webcite
• [16]Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis [http://clinicaltrials.gov/ct2/show/NCT00076843?term=ham+tsp&rank=7 webcite]
• [17]Raltegravir for HAM/TSP [http://clinicaltrials.gov/ct2/show/NCT01867320?term=ham+tsp&rank=1 webcite]
• [18]Choi I, Tanosaki R, Uike N, Utsunomiya A, Tomonaga M, Harada M, Yamanaka T, Kannagi M, Okamura J: Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials. Bone Marrow Transpl 2011, 46:116-118.
• [19]Puccioni-Sohler M, Gasparetto E, Cabral-Castro MJ, Slatter C, Vidal CM, Cortes RD, Rosen BR, Mainero C: HAM/TSP: association between white matter lesions on magnetic resonance imaging, clinical and cerebrospinal fluid findings. Arquivos de neuro-psiquiatria 2012, 70:246-251.
• [20]Utsunomiya A: Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma. Retrovirology 2014, 11:O3. BioMed Central Full Text
• [21]Maeda Y, Eguchi G, Kumode T, Yamaguchi T: Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T-cell leukemia: A risk of opportunistic infection after treatment with anti-CCR4 antibodies. Retrovirology 2014, 11:P15. BioMed Central Full Text
• [22]Yonekura K, Kanzaki T, Nakano N, Tokunaga M, Kubota A, Takeuchi S, Takatsuka Y, Utsunomiya A: Effect of a novel anti-CCR4 monoclonal antibody (Mogamulizmab) on skin lesions of adult T-cell leukemia-lymphoma (ATL) and its adverse skin reactions (ASR). Retrovirology 2014, 11:P24. BioMed Central Full Text
• [23]Pimentel A, Reis I, Chapman-Fredricks JR, Ramos JC: Clinical Features and Outcome of Adult T-cell leukemia/lymphoma: University of Miami Experience. Retrovirology 2014, 11:O1. BioMed Central Full Text
• [24]Hodson A, Demontis MA, Cook L, Gillet N, Melamed A, Bangham CRM, Taylor GP: Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α. Retrovirology 2014, 11:O5. BioMed Central Full Text
• [25]Kchour G, Rezaee SAR, Farid R, Ghantous A, Rafatpana H, Tarhini M, Kooshyar MM, El Hajj H, Berry F, Nasser R, Shirdel R, Dassouki Z, Ezzedine M, Rahimi H, Ghavamzadeh A, de Thé H, Hermine O, Mahmoudi M, Bazarbachi A: The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” micro-environment in patients with adult T-cell leukemia lymphoma. Retrovirology 2014, 11:O4. BioMed Central Full Text
• [26]Belrose G, Gazon H, Meniane JC, Olindo S, Mesnard JM, Péloponèse JM, Césaire R: Effects of valproate on Tax and HBZ expression in ex vivo cultured ATL cells. Retrovirology 2014, 11:P39. BioMed Central Full Text
• [27]Oka T, Fujita H, Abd Al-Kader L, Murakami I, Utsunomiya A, Yoshino T: Sensitive detection and apoptotic cell death induction of adult T-cell leukemia/lymphoma (ATL) cells with photodynamic actions. Retrovirology 2014, 11:P5. BioMed Central Full Text
• [28]Phillips AA, Giddings J, Horwitz SM: A phase II study of lenalidomide in patients with relapsed or refractory ATLL. Retrovirology 2014, 11:P4. BioMed Central Full Text
• [29]Suehiro Y, Hasegawa A, Iino T, Sasada A, Watanabe N, Choi I, Fukuda T, Takaishi S, Tanosaki R, Utsunomiya A, Miura O, Matsuoka M, Teshima T, Akashi K, Okamura J, Kannagi M, Uike N: The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes. Retrovirology 2014, 11:O2. BioMed Central Full Text
• [30]Takemoto S, Uzawa K, Morita K, Pornkuna R, Haga Y, Iwanaga M, Sagara Y, Kawano F, Watanabe T: Adult T-cell leukemia/lymphoma following elevation of serum levels of soluble cytokine receptors, sCD25 and sCD30. Retrovirology 2014, 11:P1. BioMed Central Full Text
• [31]Pornkuna R, Takemoto S, Hidaka M, Haga Y: Soluble CD30 is a new biomarker to predict two-year overall survival of adult T cell leukemia/lymphoma patients. Retrovirology 2014, 11:P2. BioMed Central Full Text
• [32]Amano M, Setoyama M: Immunotherapeutic potential of varicella vaccine in smoldering and cutaneous adult T-cell leukemia/lymphoma. Retrovirology 2014, 11:P21. BioMed Central Full Text
• [33]Kagdi H, Melamed A, Hilburn S, Gillet N, Hodson A, Demontis MA, Rowan A, Cook L, Bangham C, Taylor G: The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma. Retrovirology 2014, 11:P9. BioMed Central Full Text
• [34]Massoud R, Enose-Akahata Y, Brunetto GS, Ohayon J, Fenton , Cortese I, Waldmann TA, Jacobson S: Clinical trial of a humanized monoclonal anti-IL15Rβ (CD122), in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP). Retrovirology 2014a, 11:O6. BioMed Central Full Text
• [35]Massoud R, Enose-Akahata Y, Tagaya Y, Azimi N, Jacobson S: BNZ-gamma peptide, a potential therapeutic agent in HTLV-1 associated myelopathy. Retrovirology 2014, 11:P14. BioMed Central Full Text
• [36]Martin F, Castro H, Gabriel C, Adonis A, Fedina A, Harrison L, Brodnicki L, Demontis MA, Babiker AG, Weber JN, Bangham CRM, Taylor GP: A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy. Retrovirology 2014, 11:P31. BioMed Central Full Text
• [37]Ahmed S, Adonis A, Hilburn S, Demontis MA, Fedina A, Haddow J, Gabriel C, Fidler S, Taylor GP: Treatment of patients with HTLV-1-associated myelopathy with methotrexate. Retrovirology 2014, 11:P33. BioMed Central Full Text
• [38]Menna-Barreto M: Managing HAM/TSP with Fampridine. Retrovirology 2014, 11:P38. BioMed Central Full Text
• [39]Adonis AGT: Using the 6 minute walk to investigate endurance in patients with HTLV associated myelopathy. Retrovirology 2014, 11:P20. BioMed Central Full Text
• [40]Martin F, Inoue E, Grassi MFR, de Almeida Kruschewsky R, Cortese I, Silva MT, Jacobson S, Galvão-Castro B, Yamano Y, Taylor G, Bland JM: Change in timed walk as primary outcome measure of treatment response in HAMLET-P: HAM/TSP MuLticentre Efficacy trial-Prednisolone. Retrovirology 2014, 11:P30. BioMed Central Full Text
• [41]Yamano Y, Sato T, Ando H, Araya N, Yagishita N, Yamauchi J, Coler-Reilly A, Utsunomiya A, Jacobson S, Izumo S: CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis. Retrovirology 2014, 11:P18. BioMed Central Full Text
• [42]Coler-Reilly ALG, Hashimoto M, Yagishita N, Sato T, Ando , Yamauchi J, Araya N, Kimura M, Yamano Y, Takata A: Nation-wide epidemiological study in Japan on HTLV-1 associated myelopathy/tropical spastic paraparesis using HAM-net, a novel patient registration system. Retrovirology 2014, 11:P17. BioMed Central Full Text
• [43]Nozuma S, Matsuura E, Matsuzaki T, Watanabe O, Kubota R, Izumo S, Takashima H: Clinical features of familial HAM/TSP. Retrovirology 2014, 11:O7. BioMed Central Full Text
• [44]Alvarez C, Verdonck K, Tipismana M, Talledo M, Rosado J, Clark D, Van Weyenbergh J, Vandamme AM, Gotuzzo E: HAM/TSP in relatives of HAM/TSP cases and in relatives of asymptomatic HTLV-1 carriers. Retrovirology 2014, 11:P37. BioMed Central Full Text
• [45]Honarbakhsh S, Taylor GP: HTLV-1 and Bronchiectasis in a UK cohort. Report and Review. Retrovirology 2014, 11:P11. BioMed Central Full Text
• [46]Boa- Sorte N, Galvao-Castro 1 AV, Borba D, Grassi MFR, Galvão-Castro B: Is age an effect modifier in the relationship between HAM/TSP and depression? Retrovirology 2014, 11:P25. BioMed Central Full Text
• [47]Gascón MRP, Mazzaro YM, Capitão CG, Jardim VBLF, Olival GS, Bermudez JV, Casseb J, Smid J, Oliveira P, Augusto C: Neuropsychological assessment in HTLV-1 infection: preliminary data of a comparative study among depression and neurocognitive impairments. Retrovirology 2014, 11:32.
• [48]Tanajura D, Castro N, Oliveira P, Orge G, Souza A, Barbosa M, Santos S, Carvalho E: Clinical manifestations in HTLV-1 infected individuals without HAM/TSP: results of an 8 years cohort. Retrovirology 2014, 11:P3. BioMed Central Full Text
• [49]Matsuzaki T, Kubota R, Takashima H, Izumo S: Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic. Retrovirology 2014, 11:P29. BioMed Central Full Text
• [50]Okajima R, Smid J, Duarte AJS, de Oliveira ACP, Casseb J, Sanches JA Jr: Correlation of HTLV-1 proviral load and lymphocyte proliferation from asymptomatic HTLV-1-positive patients and HAM/TSP patients associated or not to skin disorders. Retrovirology 2014, 11:P16. BioMed Central Full Text
• [51]de Lourdes BM, Souza A, Carvalho N, Neves Y, Santos S, Carvalho EM: Prevalence and influence of tuberculosis in the neurologic manifestations of the Human T cell lymphotropic virus type 1 (HTLV-1). Retrovirology 2014, 11:P6. BioMed Central Full Text
• [52]Labanca L, Starling ALB, Pereira SRS, Cláudio FLR, Carneiro-Proietti ABF, Carvalho LN, Fernandes DR, Gonçalves DU: Vestibulospinal tract dysfunction in HTLV-1-asymptomatic infection and in HAM/TSP. Retrovirology 2014, 11:26.
• [53]Cunha L, Labanca L, Carneiro-Proietti ABF, Carvalho LN, Fernandes DR, Starling ALB, Gonçalves DU: Contribution of galvanic vestibular stimulation for the diagnosis of HAM/TSP. Retrovirology 2014, 11:P27. BioMed Central Full Text
• [54]Brunetto GS, Massoud R, Ohayon J, Fenton K, Cortese I, Jacobson S: Digital Droplet PCR for precise quantification of Human T-lymphotropic virus 1 proviral loads. Retrovirology 2014, 11:P13. BioMed Central Full Text
• [55]Bassi SS, Coutinho R Jr, Olavarria VN, Martin F, Galvão-Castro B, Grassi MFR: HTLV-1 proviral load as an indicative marker of HAM/TSP: a systematic review of studies of patients with HAM/TSP. Retrovirology 2014, 11:P36. BioMed Central Full Text
• [56]Bastos RHC, Silva LC, Reiss DB, Freitas GS, Souza MA, Horiguchi CLF, Ribas JGRS, Aline M, Martins ML, da Ferreira SD, Martins T, Proietti ABFC, Romanelli LCF: Amendment on brain signal intensity on magnetic resonance imaging of asymptomatic HTLV-1 seropositive and HTLV-1 associated myelopathy. Retrovirology 2014, 11:10. BioMed Central Full Text
• [57]Romanelli LCF, Bastos RHC, Silva LC, Martins T, Reiss DB, Freitas GS, Souza MAH, Cláudia LF, Ribas JGR, Silva AM, Proietti FA, Martins ML, da SD Ferreira A, Proietti ABFC: Sensitivity and specificity of spinal cord magnetic resonance imaging in the diagnosis of HTLV-1 associated myelopathy. Retrovirology 2014, 11:12. BioMed Central Full Text
• [58]Bahia F, Abrahão MH, Netto EM, Bozza, Brites C: HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance. Retrovirology 2014, 11:O8. BioMed Central Full Text
• [59]Matsuura E, Nozuma S, Matsuzaki T, Watanabe O, Kubota R, Izumo S, Takashima H: Inflammation with HTLV-1-specific CTLs occurs in the spinal cord of HTLV-1 carriers and the brain of the patients with HAM/TSP. Retrovirology 2014, 11:P7. BioMed Central Full Text
• [60]Einsiedel L, Cassar O, Goeman E, Spelman T, Gessain A: HTLV-1 associated bronchiectasis among Indigenous Australians is associated with higher HTLV-1 proviral loads: results of a prospective case–control study. Retrovirology 2014, 11:P28. BioMed Central Full Text
• [61]Hajj HE, Nasr R, Kfoury Y, Dassouki Z, Nasser R, Kchour G, Hermine O, de The H, Bazarbachi A: Animal models on HTLV-1 and related viruses: what did we learn? Front Microbiol 2012, 3:333.
• [62]Lezin A, Olindo S, Belrose G, Signate A, Cesaire R, Smadja D, Macallan D, Asquith B, Bangham C, Bouzar A, Gillet N, Defoiche J, Florins A, Verlaeten O, Burny A, Willems L: Gene activation therapy: from the BLV model to HAM/TSP patients. Front Biosci (Schol Ed) 2009, 1:205-215.
• [63]Martínez C, Gutiérrez G, Alvarez I, Porta N, Lomónaco M, Wigdorovitz A, Chacana P, Trono K: Egg yolk antibodies (IgY) against bovine leukemia virus. Retrovirology 2014, 11:P45. BioMed Central Full Text
• [64]Rodríguez SM, Gutiérrez G, Gillet N, Trono K, Willems L: A recombinant attenuated candidate vaccine that efficiently and persistently protects against bovine leukemia virus in herds. Retrovirology 2014, 11:O10. BioMed Central Full Text
• [65]Achachi A, Florins A, Gillet N, Debacq C, Urbain P, Foutsop GM, Vandermeers F, Jasik A, Reichert M, Kerkhofs P, Lagneaux L, Burny A, Kettmann R, Willems L: Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc Natl Acad Sci USA 2005, 102:10309-10314.
• [66]Olindo S, Belrose G, Gillet N, Rodriguez S, Boxus M, Verlaeten O, Asquith B, Bangham C, Signate A, Smadja D, Lezin A, Cesaire R, Willems L: Safety of long-term treatment of HAM/TSP patients with valproic acid. Blood 2011, 118:6306-6309.
• [67]Dodon MD, Villaudy J, Gazzolo L, Haines R, Lairmore M: What we are learning on HTLV-1 pathogenesis from animal models. Front Microbiol 2012, 3:320.
• [68]Albrecht B, Collins ND, Burniston MT, Nisbet JW, Ratner L, Green PL, Lairmore MD: Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes. J Virol 2000, 74:9828-9835.
• [69]Bartoe JT, Albrecht B, Collins ND, Robek MD, Ratner L, Green PL, Lairmore MD: Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol 2000, 74:1094-1100.
• [70]Collins ND, Newbound GC, Albrecht B, Beard JL, Ratner L, Lairmore MD: Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 1998, 91:4701-4707.
• [71]Silverman LR, Phipps AJ, Montgomery A, Ratner L, Lairmore MD: Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol 2004, 78:3837-3845.
• [72]Kimata JT, Wong FH, Wang JJ, Ratner L: Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 1994, 204:656-664.
• [73]Valeri VW, Hryniewicz A, Andresen V, Jones K, Fenizia C, Bialuk I, Chung HK, Fukumoto R, Parks RW, Ferrari MG, Nicot C, Cecchinato V, Ruscetti F, Franchini G: Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood 2010, 116:3809-3817.
• [74]Miura M, Tanabe J, Sugata K, Zhao T, Ma G, Miyazato P, Yasunaga JI, Matsuoka M: STLV-1-infected Japanese macaque as a model of HTLV-1 infection. Retrovirology 2014, 11:O12. BioMed Central Full Text
• [75]Pise-Masison C, de Castro-Amarante MF, Buchmann C, Enoso-Akahata Y, Fenezia C, Edwards D, Alcantara LC Jr, Bialuk I, Jacobson S, Galvao-Castro B, Gessain A, Franchini G: Both orf-I isoforms, p12 and p8, are required for efficient HTLV-1 infection and persistence. Retrovirology 2014, 11:O13. BioMed Central Full Text
• [76]Souquière S, Kazanji M: Co-infection of Mandrills with SIVmnd and STLV-1: Implications for clinical outcome. Retrovirology 2014, 11:P41. BioMed Central Full Text
• [77]Ohsugi T: A transgenic mouse model of human T cell leukemia virus type 1-associated diseases. Front Microbiol 2013, 4:49.
• [78]Ohsugi T, Wakamiya M, Morikawa S, Matsuura K, Kumasaka T, Yamaguchi K: HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)-like disease and toxic epidermal necrolysis (TEN)-like disease in HTLV-1 Tax transgenic mice. Retrovirology 2014, 11:P40. BioMed Central Full Text
• [79]Gao L, Deng H, Zhao H, Hirbe A, Harding J, Ratner L, Weilbaecher K: HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition. Blood 2005, 106:4294-4302.
• [80]Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L: Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1995, 92:1057-1061.
• [81]Rauch D, Gross S, Harding J, Niewiesk S, Lairmore M, Piwnica-Worms D, Ratner L: Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood 2009, 113:1493-1500.
• [82]Gross S, Gammon ST, Moss BL, Rauch D, Harding J, Heinecke JW, Ratner L, Piwnica-Worms D: Bioluminescence imaging of myeloperoxidase activity in vivo. Nat Med 2009, 15:455-461.
• [83]Rauch DA, Harding JC, Ratner L: IL-15 Deficient tax mice reveal a role for IL-1α in tumor immunity. Retrovirology 2014, 11:O11. BioMed Central Full Text
• [84]Kwon H, Ogle L, Benitez B, Bohuslav J, Montano M, Felsher DW, Greene WC: Lethal cutaneous disease in transgenic mice conditionally expressing type I human T cell leukemia virus Tax. J Biol Chem 2005, 280:35713-35722.
• [85]Yamazaki J, Mizukami T, Takizawa K, Kuramitsu M, Momose H, Masumi A, Ami Y, Hasegawa H, Hall WW, Tsujimoto H, Hamaguchi I, Yamaguchi K: Identification of cancer stem cells in a tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma. Blood 2009, 114:2709-2720.
• [86]El Hajj H, El-Sabban M, Hasegawa H, Zaatari G, Ablain J, Saab ST, Janin A, Mahfouz R, Nasr R, Kfoury Y, Nicot C, Hermine O, Hall W, de The H, Bazarbachi A: Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. J Exp Med 2010, 207:2785-2792.
• [87]Ikebe E, Kawaguchi A, Tezuka K, Taguchi S, Hirose S, Matsumoto T, Mitsui T, Senba K, Nishizono A, Hori M, Hasegawa H, Yamada Y, Ueno T, Tanaka Y, Sawa H, Hall W, Minami Y, Jeang KT, Ogata M, Morishita K, Hasegawa H, Fujisawa JI, Iha H: A novel HSP90 inhibitor, 17-DMAG, induces tax down-regulation and its oral administration to ATL-model mice intervenes against the infiltration property of the ATL-like lymphocytes and provides extended survival period. Retrovirology 2014, 11:P44. BioMed Central Full Text
• [88]Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, Yamaguchi T, Ono M, Sakaguchi S, Matsuoka M: HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog 2011, 7:e1001274.
• [89]Villaudy J, Wencker M, Gadot N, Gillet NA, Scoazec JY, Gazzolo L, Manz MG, Bangham CR, Dodon MD: HTLV-1 propels thymic human T cell development in “human immune system” Rag2(−)/(−) gamma c(−)/(−) mice. PLoS Pathog 2011, 7:e1002231.
• [90]Saito M, Tanaka R, Kodama A, Tanaka Y: Complete prevention of HTLV-1 infection in humanized mice (hu-PBL SCID) by a neutralizing monoclonal antibody to envelope gp46. Retrovirology 2014, 11:O9. BioMed Central Full Text
• [91]Tezuka K, Tei M, Ueno T, Xun R, Fujisawa JI: Carrier model of HTLV-1 infection in humanized NOG mice. Retrovirology 2014, 11:P42. BioMed Central Full Text
• [92]Tezuka K, Tei M, Ueno T, Xun R, Iha H, Fujisawa JI: Inhibition of ATL development in humanized mouse model by AZT/INF treatment. Retrovirology 2014, 11:P43. BioMed Central Full Text
• [93]Gessain A, Cassar O: Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 2012, 3:388.
• [94]Gessain A, Cassar O: HTLV-1 world distribution and estimation of the number of asymptomatic infected carriers. Retrovirology 2014, 11:O14. BioMed Central Full Text
• [95]Usadi B, Bruhn R, Lin J, Lee TH, Blackburn E, Murphy EL: Telomere length, proviral load and neurologic impairment in HTLV-1-and HTLV-2-infected humans. Retrovirology 2014, 11:O15. BioMed Central Full Text
• [96]Pataccini G, Cánepa C, Salido J, Delfino CM, Blejer J, Fernández R, Rodríguez E, Alter A, Pedrozo W, Malan R, Iriarte E, Duarte G, Schneider V, Bontti S, Salomón C, Borda M, Biglione MM, Berini CA: Comparison of human T cell leukemia virus-1/2 (HTLV-1/2) screening assays in South America: implications in the loss of blood units. Retrovirology 2014, 11:O16. BioMed Central Full Text
• [97]de Campos CCC, Galvão-Barroso AK, Novais H, Carvalho M, Araújo BL, Boa-Sorte N, Grassi MF, Barroso U Jr, Galvão-Castro B: Impact of urinary incontinence on the quality of life (QoL) of women living with HTLV-1 in Salvador. Brazil. Retrovirology 2014, 11:O17. BioMed Central Full Text
• [98]dos Santos TA, de Souza FV, Gaester KA, da Silva DC, Fonseca LAM, Luiz ODC, Pinho JRR, Duarte AJS, de Oliveira AP, Casseb J: IL28B gene polymorphism SNP rs8099917 allele GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers. Retrovirology 2014, 11:O18. BioMed Central Full Text
• [99]Gadelha SR, Aleluia MM, Mello MAG, Rego FFA, Pereira LSG-C, Gonçalves BM, Sousa SMB, Alcantara LC: Interfamilial transmission of HTLV-1 in the South of Bahia Brazil. Retrovirology 2014, 11:P50. BioMed Central Full Text
• [100]Gadelha SR, Aleluia MM, Mello MAG, Rego FFA, Pereira LSG-CB, Gonçalves M, Sousa SMB, Alcantara LC: The origin of HTLV-1 in the South Bahia by phylogenetic, mitochondrial DNA and β-globin analysis. Retrovirology 2014b, 11:49.
• [101]Reiss DB, Freitas GS, Rafael HC B, de Souza MA, Cláudia LF H, Martins ML, Anísia SD F, Starling ALB, Romanell LCF, Anna Bárbara FC P: Neurological outcomes analysis of HTLV-1 seropositive patients of the interdisciplinary research HTLV Group (GIPH) cohort, Brazil. Retrovirology 2014, 11:51.
• [102]Romanelli LC, Caramelli P, Martins ML, Goncalves DU, Proietti FA, Ribas JG, Araujo MG, Carneiro-Proietti AB: Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil. AIDS Res Human Retroviruses 2013, 29:1199-1202.
• [103]Cláudia LF H, de Souza MA, Reiss DB, Freitas GS, Rafael HC B, Martins ML, Proietti FA, Romanelli LCF, Lopes MSN, Carneiro-Proiett ABF: HTLV-1 and 2 in family groups in Belo Horizonte, Brazil: prevalence and routes of contamination. Retrovirology 2014, 11:53.
• [104]Chang YB, Kaidarova Z, Hindes D, Bravo M, Kiely N, Kamel H, Dubay D, Hoose B, Murphy EL: Seroprevalence of Human T-lymphotropic virus type-1 and −2 infections among first-time United States blood donors 2000–2009. Retrovirology 2014, 11:P61. BioMed Central Full Text
• [105]Switzer WM, Shankar A, Trimble SRT AA, Giardina PJ, Cohen AR, Coates TD, Vichinsky E, Neufeld EJ, Boudreaux JMHW: Human T-cell lymphotropic virus type 1 infection among U.S. Thalassemia patients. Retrovirology 2014, 11:P54. BioMed Central Full Text
• [106]Switzer WM, Shankar A, Trimble SR, Thompson AA, Giardina PJ, Cohen AR, Coates TD, Vichinsky E, Neufeld EJ, Boudreaux JM, Heneine W: Human T cell lymphotropic virus type 1 infection among U.S. thalassemia patients. AIDS Res Human Retroviruses 2013, 29:1006-1009.
• [107]Croxford SE, Delpech VC, Jennifer HC T, Katy D, Taylor GP: Epidemiology of Human T-cell lymphotropic viruses (HTLV) in England and Wales, 2003–2012. Retrovirology 2014, 11:P60. BioMed Central Full Text
• [108]Cassar O, Einsiedel L, Afonso PV, Gessain A: HTLV-1 molecular epidemiology in central Australia: two distinctive HTLV-1 Subtype C lineages in Indigenous Australians. Retrovirology 2014, 11:56.
• [109]Filippone C, Betsem E, Bassot S, Tortevoye P, Froment A, Fontanet AM, Gessain A: High frequency of HTLV-1 infection in Bantus and Pygmies from rural Cameroon bitten by non-human primates during hunting. Retrovirology 2014, 11:P57. BioMed Central Full Text
• [110]Fox JM, Newton R, Bedaj M, Bland JM, Mutalima N, Martin F: Sero-prevalence of HTLV 1/2 and HCV in paired mother and children from Malawi as well as systematic review and meta-analysis of HTLV-1/2 and HCV of data available on women and children living in Africa. Retrovirology 2014, 11:P58. BioMed Central Full Text
• [111]Choudhury B, Finnegan C, Frossard JP, Venables C, Steinbach F: Colostrum replacer and bovine leukaemia virus sero-positivity. Retrovirology 2014, 11:P59. BioMed Central Full Text
• [112]Sze A, Belgnaoui SM, Lin R, van Grevenynghe J, Hiscott J: Host restriction factor SAMHD1 limits human T-cell leukemia virus (HTLV-1) infection of primary monocytes via the innate immune sensor STING. Retrovirology 2014, 11:O19. BioMed Central Full Text
• [113]Alais S, Glaize A, Cachat A, Lamouche F, Mahieux R, Dutartre H: Distinct DC subsets are not equally susceptible to HTLV-1 infection. Retrovirology 2014, 11:O20. BioMed Central Full Text
• [114]de Castro-Amarante MF, Pise-Masison C, McKinnon K, Massoud R, Jacobson S, Franchini G: The contribution of monocytes/macrophages to HTLV-1 infection and persistence. Retrovirology 2014, 11:P123. BioMed Central Full Text
• [115]Rahman S, Khan ZK, Wigdahl B, Jennings S, Tangy F, Jain P: Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection. Retrovirology 2014, 11:P70. BioMed Central Full Text
• [116]Rahman S, Manuel SL, Khan ZK, Wigdahl B, Acheampong E, Tangy F, Jain P: Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice. Retrovirology 2014, 11:P71. BioMed Central Full Text
• [117]Kinpara S, Kijiyama M, Takamori A, Hasegawa A, Sasada A, Masuda T, Tanaka Y, Utsunomiya A, Kannagi M: IFN-α suppresses HTLV-1 expression via PKR in infected cells and renders them susceptible to AZT through p53 activation in AZT/IFN-α treatment. Retrovirology 2014, 11:O24. BioMed Central Full Text
• [118]Khouri R, Silva-Santos G: Farre l, Bittencourt A, Vandamme AM, Van Weyenbergh J: superior antiviral and antiproliferative activity of IFN-beta vs. IFN-alpha in primary ATL cells occurs downstream of STAT1 signaling. Retrovirology 2014, 11:022.
• [119]Van Weyenbergh J, Decanine D, Schnitman SV, Moro AM, Kalil J, Kruschewsky RA, Galvão-Castro B: Anti-CD3 monoclonal antibody as a possible therapeutic alternative in HAM/TSP. Retrovirology 2014, 11:O40. BioMed Central Full Text
• [120]Campuzano-Zuluaga G, Pimentel A, Chapman-Fredricks JR, Ramos JC: Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes. Retrovirology 2014, 11:P129. BioMed Central Full Text
• [121]Uto T, Akagi T, Akashi M, Baba M: HTLV-1 Tax peptide-carrying polyion complex nanoparticles induce potent cellular immunity in mice. Retrovirology 2014, 11:P63. BioMed Central Full Text
• [122]Enose-Akahata Y, Abrams A, Massoud R, Bialuk I, Johnson KR, Green PL, Maloney EM, Jacobson S: Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals. Retrovirology 2014, 11:O23. BioMed Central Full Text
• [123]Rowan AG McCallin A, Niederer HA, Hilburn S, Cook L, Taylor GP, Bangham CRM: HTLV-1 gene expression by individual infected clones determines susceptibility to lysis by cytotoxic T lymphocytes specific for Tax and HBZ. Retrovirology 2014, 11:O21. BioMed Central Full Text
• [124]Niederer H, Laydon D, Melamed A, Elemans M, Asquith B, Matsuoka M, Bangham C: Integration site analysis in Japanese HTLV-1 infected asymptomatic carriers and HAM/TSP patients. Retrovirology 2014, 11:P69. BioMed Central Full Text
• [125]Santos S, Toledo C, Souza A, Tanajura D, Glesby M, Carvalho EM: Immune response, proviral load and serologic markers of neurologic disease expression in HTLV-1 infection. Retrovirology 2014, 11:P67. BioMed Central Full Text
• [126]Cilião-Alves DC, Rocha-Junior MCH R, Wagatsuma VMD, Takayanagui OM, Covas DT, Kashima S, Donadi EA: HLA-G 3142C/G polymorphism is related to development of symptoms in HTLV-1 infected individuals. Retrovirology 2014, 11:740.
• [127]Olavarria VN, dos Santos EJM, dos Santos SEB, Grassi F, Kruchewesky R, Pôrto LCMS, Gao X, Carrington M, Galvão-Castro B: Do African and European ancestry and polymorphism of HLA class I play an important role in controlling HTLV-1 proviral load in admixed cohorts from Salvador, Brazil? Retrovirology 2014, 11:P76. BioMed Central Full Text
• [128]Pinto MT, Malta TM, Pinheiro DG, Rodrigues ES, Panepucci RA, Sousa AP, Malmegrim KCR, Palma PVB, Takayanagui OM, Covas DT, Kashima S: Genes related to antiviral activity are differentially expressed in CD4+ T cell in HAM/TSP patients. Retrovirology 2014, 11:P75. BioMed Central Full Text
• [129]Menezes SM, Decanine D, Khouri R, Schnitman SV, Kruschewsky RA, Vandamme AM, Galvão-Castro B, Van Weyenbergh J: A selective defect in Fas-mediated apoptosis in HAM/TSP: an ex vivo, in vitro and in silico study. Retrovirology 2014, 11:P78. BioMed Central Full Text
• [130]Anderson MR, Akahata Y, Massoud R, Ngouth N, Oh U, Jacobson S: HTLV-1 epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional proliferative suppression of Tregs. Retrovirology 2014, 11:O34. BioMed Central Full Text
• [131]Twigger K, Rowan A, Al Basatena NKS, MacNamara A, Retiere C, Gould K, Taylor GP, Asquith B, Bangham CRM: Frequency and function of KIR+ CD8+ T cells in HTLV-1 infection. Retrovirology 2014, 11:P79. BioMed Central Full Text
• [132]Tanaka Y, Takahashi Y, Kodama A, Tanaka R, Saito M: Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection. Retrovirology 2014, 11:O39. BioMed Central Full Text
• [133]Sato T, Ando H, Tomaru U, Yoshida M, Utsunomiya A, Yamauchi J, Araya N, Yagishita N, Coler-Reilly A, Jacobson S, Yamano Y: Virus-induced CXCL10-CXCR3 positive feedback loop via astrocytes is critical for maintaining chronic inflammatory lesions in HAM/TSP. Retrovirology 2014, 11:O25. BioMed Central Full Text
• [134]Enose-Akahata Y, Massoud R, Virtanen JO, Jacobson S: Correlation of increased CXCL13 with intrathecal humoral immune responses to HTLV-1 in CSF of patients with HAM/TSP. Retrovirology 2014, 11:O38. BioMed Central Full Text
• [135]Jin DY, Kok KHT HMV, Lui PY, Chan CP: Suppression of type I interferon production by human T-cell leukemia virus type 1 oncoprotein Tax. Retrovirology 2014, 11:P77. BioMed Central Full Text
• [136]Souza AS, Amorim CF, Carvalho N, Santos SBC EM: Impairment of humoral and cellular immune response to tetanus toxoid in HTLV-1 infected individuals. Retrovirology 2014, 11:P66. BioMed Central Full Text
• [137]Kodama D, Izumo K, Kubota R, Matsuzaki T, Takashima H, Izumo S: Characterization of glycans of CD4 + T cells in HAM/TSP. Retrovirology 2014, 11:O69. BioMed Central Full Text
• [138]Barez PY, Carpentier A, Boxus M, Willems L: The tax protein and the minichromosome maintenance protein complex MCM2-7 affect cell replication and viral transcription. Retrovirology 2014, 11:P96. BioMed Central Full Text
• [139]Mocquet V, Neusiedler J, Rende F, Cluet D, Robin JP, Terme JM, Duc-Dodon M, Morris C, Le Hir H, Ciminale V, Jalinot P: Nonsense-mediated mRNA decay inhibition by HTLV-1 Tax protein. Retrovirology 2014, 11:O61. BioMed Central Full Text
• [140]Pène S, Bonnet A, Waast L, Bénit L, Pique C: The SUMOylation machinery is dispensable for Tax-induced NF-kB activation. Retrovirology 2014, 11:O60. BioMed Central Full Text
• [141]Barbeau B, Peloponese JM, Mesnard JM: Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis. Front Microbiol 2013, 4:226.
• [142]Goicochea M, Nata T, Gallo R, Cheng H, Tagaya Y: HBZ RNA may promote cell survival against clastogenic damages and thereby contributes to the development of leukemic ATL cells. Retrovirology 2014, 11:O56. BioMed Central Full Text
• [143]Vernin C, Pinatel C, Gessain A, Gout O, Delfau-Larue MH, Nazaret N, Legras-Lachuer C, Wattel E, Mortreux F: The HTLV-1 encoded bZIP factor promotes cell proliferation and genetic instability through activation of oncogenic microRNAs. Retrovirology 2014, 11:O43. BioMed Central Full Text
• [144]Gazon H, Mesnard JM, Césaire R, Peloponese JM Jr: Deregulation of RNAi silencing pathway by human T-cell leukemia virus type 1 bZIP factor (HBZ). Retrovirology 2014, 11:O55. BioMed Central Full Text
• [145]Polakowski N, Terol M, Nash I, Hoang K, Gazon H, Wurm T, Césaire R, Péloponèse JM, Mesnard JM, Lemasson I: A BDNF/TrKB autocrine loop stimulated by HBZ is involved in HTLV-1-infected cell-survival. Retrovirology 2014, 11:O57. BioMed Central Full Text
• [146]Ma G, Yasunaga JI, Fan J, Yanagawa SI, Matsuoka M: HTLV-1-mediated dysregulation of the Wnt pathways: roles of Tax and HBZ. Retrovirology 2014, 11:P91. BioMed Central Full Text
• [147]Chevalier SA, Pise-Masison CA, Gessain A, Mahieux R: Transcriptomic analyses reveal that the cellular Gem protein promotes HTLV-1 infected cell migration and viral transmission. Retrovirology 2014, 11:O64. BioMed Central Full Text
• [148]Panfil AR, Al-Saleem JJ, Baiocchi RA, Green PL: Role of protein arginine methyltransferase 5 over-expression in HTLV-1-driven cellular transformation and leukemia. Retrovirology 2014, 11:O65. BioMed Central Full Text
• [149]Marçais A, Hanssens K, Cook L, Mercher T, Gaulard P, Asnafi V, Pique C, Bazarbachi A, Suarez F, Bernard O, Bangham CRM, Dubreuil P, Hermine O: Recurrent TET2 mutations in adult T cell leukemia. Retrovirology 2014, 11:P119. BioMed Central Full Text
• [150]Thenoz M, Vernin C, Pinatel C, Nazaret N, Lachuer J, Gessain A, Auboeuf D, Wattel E, Mortreux F: Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals. Retrovirology 2014, 11:O66. BioMed Central Full Text
• [151]Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, Matsuda Y, Sato-Otsubo A, Muto S, Utsunomiya A, Yamaguchi K, Uchimaru K, Ogawa S, Watanabe T: Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012, 21:121-135.
• [152]Yamagishi M, Fujikawa D, Kurokawa N, Soejima A, Takahashi R, Sakai N, Nakagawa S, Nakano K, Kobayashi S, Utsunomiya A, Yamaguchi K, Uchimaru K, Ogawa S, Watanabe T: Molecular hallmarks of adult T cell leukemia: miRNA, epigenetics, and emerging signaling abnormalities. Retrovirology 2014, 11:O54. BioMed Central Full Text
• [153]Durkin K, Rosewick N, Momont M, Thys W, Burny A, Georges M, Van den Broeke A: Elucidating the role of bovine leukemia virus encoded micro-RNAs. Retrovirology 2014, 11:O62. BioMed Central Full Text
• [154]Gillet NA, Gutiérrez G, de Brogniez A, Rodriguez SM, Renotte N, Alvarez I, Vagnoni L, Trono K, Willems L: Massive depletion of BLV proviral clones located in genomic transcriptionally active sites during primary infection. Retrovirology 2014, 11:O63. BioMed Central Full Text
• [155]Switzer WM, Heneine W: Foamy viruses. In Molecular Detection of Viral Pathogens. Edited by Liu D. Boca Raton: CRC Press; 2011:131-146.
• [156]Kearney MF, Spindler J, Wiegand A, Shao W, Anderson EM, Maldarelli F, Ruscetti FW, Mellors JW, Hughes SH, Le Grice SF, Coffin JM: Multiple sources of contamination in samples from patients reported to have XMRV infection. PloS One 2012, 7:e30889.
• [157]Alter HJ, Mikovits JA, Switzer WM, Ruscetti FW, Lo SC, Klimas N, Komaroff AL, Montoya JG, Bateman L, Levine S, Peterson D, Levin B, Hanson MR, Genfi A, Bhat M, Zheng H, Wang R, Li B, Hung GC, Lee LL, Sameroff S, Heneine W, Coffin J, Hornig M, Lipkin WI: A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus. mBio 2012., 3Doi:10.1128/mBio.00266-12
• [158]Delviks-Frankenberry K, Cingoz O, Coffin JM, Pathak VK: Recombinant origin, contamination, and de-discovery of XMRV. Current Opinion in Virology 2012, 2:499-507.
• [159]Huang F, Wang H, Jing S, Zeng W: Simian foamy virus prevalence in Macaca mulatta and zookeepers. AIDS Res Human Retroviruses 2012, 28:591-593.
• [160]Switzer W, Ahuka-Mundeke S, Tang S, Shankar A, Wolfe N, Heneine W, Peeters M, Ayouba A, Mulembakani P, Rimoin A: Simian Foamy Virus (SFV) infection from multiple monkey species in women from the Democratic Republic of Congo. Retrovirology 2011, 8:A233. BioMed Central Full Text
• [161]Betsem E, Rua R, Tortevoye P, Froment A, Gessain A: Frequent and recent human acquisition of simian foamy viruses through apes’ bites in central Africa. PLoS Pathog 2011, 7:e1002306.
• [162]Rua R, Betsem E, Montange T, Buseyne F, Gessain A: Latency, tropism and genetic variation of simian foamy virus in blood and saliva from infected Humans. Retrovirology 2014, 11:O71. BioMed Central Full Text
• [163]Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, Torimiro JN, Prosser AT, Lebreton M, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Switzer WM: Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci USA 2005, 102:7994-7999.
• [164]Choudhary A, Galvin TA, Williams DK, Beren J, Bryant MA, Khan AS: Influence of naturally occurring simian foamy viruses (SFVs) on SIV disease progression in the rhesus macaque (Macaca mulatta) model. Viruses 2013, 5:1414-1430.
• [165]Switzer WM, Garcia AD, Yang C, Wright A, Kalish ML, Folks TM, Heneine W: Coinfection with HIV-1 and simian foamy virus in West Central Africans. J Infect Dis 2008, 197:1389-1393.
• [166]Calattini S, Betsem E, Bassot S, Chevalier SA, Mahieux R, Froment A, Gessain A: New strain of human T lymphotropic virus (HTLV) type 3 in a Pygmy from Cameroon with peculiar HTLV serologic results. J Infect Dis 2009, 199:561-4.
• [167]Zheng H, Wolfe ND, Sintasath DM, Tamoufe U, Lebreton M, Djoko CF, Diffo Jle D, Pike BL, Heneine W, Switzer WM: Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon. Virology 2010, 401:137-145.
• [168]Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R, Gessain A: Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2005, 2:30. BioMed Central Full Text
• [169]Switzer WM, Qari SH, Wolfe ND, Burke DS, Folks TM, Heneine W: Ancient origin and molecular features of the novel human T-lymphotropic virus type 3 revealed by complete genome analysis. J Virol 2006, 80:7427-7438.
• [170]Calattini S, Chevalier SA, Duprez R, Afonso P, Froment A, Gessain A, Mahieux R: Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein. J Virol 2006, 80:9876-9888.
• [171]Switzer WM, Salemi M, Qari SH, Jia H, Gray RR, Katzourakis A, Marriott SJ, Pryor KN, Wolfe ND, Burke DS, Folks TM, Heneine W: Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology 2009, 6:9. BioMed Central Full Text
• [172]Chevalier SA, Meertens L, Pise-Masison C, Calattini S, Park H, Alhaj AA, Zhou M, Gessain A, Kashanchi F, Brady JN, Mahieux R: The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax. Oncogene 2006, 25:4470-4482.
• [173]Larocque É, André-Arpin C, Mesnard JM, Switzer WM, Barbeau B: HTLV-3 and HTLV-4 antisense proteins enhance the transactivation potential of several Jun family members through interaction via their bZIP-like domain. Retrovirology 2014, 11:O72. BioMed Central Full Text
• [174]Larocque E, Halin M, Landry S, Marriott SJ, Switzer WM, Barbeau B: Human T-cell lymphotropic virus type 3 (HTLV-3)- and HTLV-4-derived antisense transcripts encode proteins with similar Tax-inhibiting functions but distinct subcellular localization. J Virol 2011, 85:12673-12685.
• [175]Weiss RA, Stoye JP: Virology. Our viral inheritance. Science 2013, 340:820-821.
• [176]Kurth R, Bannert N: Beneficial and detrimental effects of human endogenous retroviruses. Int J Canc Suppl J Int Canc Suppl 2010, 126:306-314.
• [177]Babaian A, Mager DL: Endogenous retroviral long terminal repeats as host gene promoters in normal and cancer cells. Retrovirology 2014, 11:P132. BioMed Central Full Text
• [178]Wang W, Indik S, Wasilenko ST, Wong GKS, Mason AL: Characterization of a human betaretrovirus in patients with primary biliary cirrhosis. Retrovirology 2014, 11:O70. BioMed Central Full Text
• [179]Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, Sander DM, Shoenfeld Y, Ahmed A, Van de Water J, Gershwin ME, Garry RF: Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998, 351:1620-1624.
• [180]Xu L, Sakalian M, Shen Z, Loss G, Neuberger J, Mason A: Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology 2004, 39:151-156.
• [181]Xu L, Shen Z, Guo L, Fodera B, Keogh A, Joplin R, O’Donnell B, Aitken J, Carman W, Neuberger J, Mason A: Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci USA 2003, 100:8454-8459.
• [182]Jones KS, Petrow-Sadowski C, Bertolette DC, Enam N, Bagni RK, Jensen SMR, Davis DA, Yarchoan R, Ruscetti FW: Different routes of entry of HTLV-1 during infection of primary dendritic cells and CD4+ T cells. Retrovirology 2014, 11:O77. BioMed Central Full Text
• [183]Cook L, Niederer H, Melamed A, Taylor GP, Matsuoka M, Bangham CRM: The structure and genomic integration site of the HTLV-1 provirus determine selective clonal expansion and transformation to adult T cell leukaemia/lymphoma. Retrovirology 2014, 11:O76. BioMed Central Full Text
• [184]Meekings KN, Leipzig J, Bushman FD, Taylor GP, Bangham CR: HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog 2008, 4:e1000027.
• [185]Melamed A, Taylor GP, Bangham CRM: Clonality of HTLV-1 differs between infected CD8+ T cells and infected CD4+ T cells in vivo. Retrovirology 2014, 11:P137. BioMed Central Full Text
• [186]Melamed A, Witkover AD, Brown R, Ladell K, Gormley N, Murphy EL, Taylor GP, Price DAB CRM: Clonality of HTLV-2 in natural infection. Retrovirology 2014b, 11:P138. BioMed Central Full Text
• [187]Laydon DJ, Melamed AS A, Gillet NA, Sim K, Darko S, Kroll JS, Douek DC, Price DA, Bangham CRM, Asquith B: Estimation of clonal diversity in HTLV-1 infection. Retrovirology 2014, 11:O50. BioMed Central Full Text
• [188]de Brogniez A, Bouzar AB, Jacques JR, Gillet N, Pritsch O, Tomé L, Reichert M, Willems L: Hyper-replicative bovine leukemia virus by mutation of an envelope N-linked glycosylation site. Retrovirology 2014, 11:P141. BioMed Central Full Text
• [189]Aida Y, Takeshima SN, Panei CJO T, Nunoya T, Davis WCI H, Matoba K: BLV-CoCoMo-qPCR: Estimation of bovine leukemia virus (BLV) proviral load harbored by lymphocyte subpopulations in BLV-infected cattle at the subclinical stage of enzootic bovine leucosis. Retrovirology 2014, 11:143. BioMed Central Full Text
• [190]Kagdi H, Melamed A, Hilburn S, Demontis MA, Bangham C, Taylor G: CD25 + CCR4+ cells as a marker of HTLV-1-infected cells in peripheral blood. Retrovirology 2014, 11:P139. BioMed Central Full Text
• [191]Gonçalves PC, Freitas GSR LCF, Proietti FA, Carneiro- Proietti ABM ML: Follow-up of HTLV-1 positive individuals in the GIPH cohort (1997–2013): proviral load was not a prognostic marker for HAM/TSP. Retrovirology 2014, 11:P23. BioMed Central Full Text
• [192]Morris C, Cowan EP: Development of a WHO Anti-HTLV Reference Panel. Retrovirology 2014, 11:P145. BioMed Central Full Text
• [193]Guendel I, Van Duyne R, Kashanchi F: Control of LTR transcription by SWI/SNF BAF and PBAF complexes. Retrovirology 2014, 11:O47. BioMed Central Full Text
• [194]Mann MC, Strobel S, Fleckenstein B, Kress AK: Upregulation of the transcription elongation factor ELL2 by Tax as a novel mechanism of HTLV-1 gene expression. Retrovirology 2014, 11:O48. BioMed Central Full Text
• [195]Van Duyne R, Guendel I, Narayanan A, Kehn-Hall K, Jaworski E, Roman J, Coley W, Klase Z, Popratiloff A, Mahieux R, Kashanchi F: Localization and sub-cellular shuttling of HTLV-1 Tax with the microRNA machinery. Retrovirology 2014, 11:O73. BioMed Central Full Text
• [196]Fujikawa D, Yamagishi M, Kurokawa N, Soejima A, Ishida T, Tanaka Y, Nakano K, Watanabe T: HTLV-1 Tax disrupts the host epigenome by interacting with a Polycomb group protein EZH2. Retrovirology 2014, 11:P144. BioMed Central Full Text
• [197]Ueno T, Xun R, Saito M, Tezuka K, Tanaka Y, Fujisawa JI: Altered pattern in viral mRNA expression of Iranian type HTLV-1 leading to enhanced viral expression. Retrovirology 2014, 11:P146. BioMed Central Full Text
• [198]Narayanan A, Jaworski E, Van Duyne R, Iordanskiy S, Guendel I, Das R, Currer R, Sampey G, Chung M, Kehn-Hall K, Bailey C, Popratiloff A, Kashanchi F: Exosomes derived from HTLV-1 infected cells contain the viral protein Tax. Retrovirology 2014, 11:O46. BioMed Central Full Text
• [199]Barrios CS, Castillo L, Wu L, Giam CZ, Beilke MA: Recombinant Tax1 and Tax2 proteins inhibit HIV-1 replication in peripheral blood mononuclear cells. Retrovirology 2014, 11:P136. BioMed Central Full Text
• [200]Huleihel M, Shvarzbeyn J: Effect of propolis and its active component CAPE on HTLV-1 Tax activities. Retrovirology 2014, 11:P135. BioMed Central Full Text
• [201]Xiang D, Yuan Y, Chen L, Belani C, Cheng H: Ubiquitination-dependent, proteasomal degradation of the retroviral oncoprotein Tax by niclosamide, an anti-helminthic molecule. Retrovirology 2014, 11:P148. BioMed Central Full Text